Enterococcus Faecalis in Vagina: Causes and Symptoms

Enterococcus faecalis is a bacterium that normally lives in the human gut but can colonize the vagina when the usual protective bacteria are depleted. It is the most common pathogen found in aerobic vaginitis, accounting for roughly 31% of cases, and its presence typically signals a shift away from the lactobacillus-dominated environment that keeps the vagina healthy.¹ Understanding how it arrives, what it does once it’s there, and when it actually needs treatment involves more nuance than a simple “infection equals antibiotics” framing.

Where E. Faecalis Comes From

E. faecalis is not a sexually transmitted organism. It lives as a normal commensal in the intestinal tract of most people, and its presence in the vagina is usually the result of translocation from the gut. The anatomy makes this straightforward: the short distance between the anus and vaginal opening means bacteria migrate between the two sites regularly. In most cases, the vagina’s resident lactobacilli keep E. faecalis from gaining a foothold. The trouble starts when that microbial defense weakens.

Once E. faecalis reaches vaginal tissue, it has specific tools for sticking around. Research on its surface proteins shows that structures called Ebp pili are required for the bacterium to attach to human vaginal and cervical cells.² Other proteins, including one that binds collagen, help it adhere to mucosal surfaces more broadly. These attachment mechanisms explain why E. faecalis can persist in the vaginal tract even after the initial disruption that let it colonize has resolved. Genome-wide studies of E. faecalis have confirmed that vaginal adherence and persistence depend on a specific set of genetic factors, and that colonization tends to increase following antibiotic treatment or in patients already experiencing aerobic vaginitis.³

What Causes Vaginal Colonization

The single biggest factor that opens the door for E. faecalis is the loss of lactobacilli. In a healthy vaginal environment, species like Lactobacillus crispatus, L. gasseri, L. iners, and L. jensenii dominate the microbial landscape. They produce lactic acid and other compounds that keep the pH low (around 3.8 to 4.5) and suppress potential pathogens.⁴ When those populations shrink or vanish, the pH rises above 5, and aerobic bacteria like E. faecalis can overgrow.¹

Several common situations cause lactobacilli to decline:

Broad-spectrum antibiotics: Courses of antibiotics prescribed for unrelated infections (sinus infections, dental work, urinary tract infections) kill lactobacilli along with the target pathogen. This leaves space for E. faecalis, which is naturally resistant to many common antibiotics.
Spermicidal products: Spermicidal ointments and creams are toxic to lactobacilli and can reduce their numbers enough to allow overgrowth of other organisms.
Hormonal shifts: Estrogen supports lactobacillus colonization by promoting glycogen production in vaginal epithelial cells. During menopause, postpartum recovery, or certain phases of hormonal contraception, estrogen levels drop and lactobacilli may decline as a result.
Vaginal douching: Flushing the vaginal canal disrupts the normal microbial balance and raises pH, creating conditions favorable for aerobic pathogens.

The relationship between estrogen and E. faecalis colonization is still being studied. One recent investigation compared postmenopausal women using vaginal estrogen with premenopausal women and found no statistically significant difference in the need for additional antibiotics to treat E. faecalis-related urinary infections between the groups.⁵ That suggests vaginal estrogen alone may not be enough to prevent E. faecalis persistence once it’s established, possibly because the bacterium’s biofilm-forming ability protects it even in an otherwise improved vaginal environment.

Symptoms of E. Faecalis in the Vagina

When E. faecalis colonizes the vagina and triggers an immune response, the result is typically aerobic vaginitis. The symptoms are distinct from those of bacterial vaginosis, and mistaking one for the other leads to wrong treatment, so the differences matter.

Aerobic vaginitis caused by E. faecalis tends to produce a sticky, yellow or yellow-green vaginal discharge that has an unpleasant rotting smell, which is different from the fishy odor associated with bacterial vaginosis. Other common symptoms include vulvar itching, burning sensations, and pain during sex. On examination, the vaginal walls appear red and inflamed, and in more severe cases there can be small areas of bleeding or erosion of the vaginal lining.¹

These symptoms often fluctuate. You might have a week where things seem to improve and then a flare that feels like starting over. The inflammation can become chronic, lasting months or even longer than a year in severe forms. When it persists at that level, it becomes difficult to distinguish from a condition called desquamative vaginitis, which shares the same features of purulent discharge, vaginal irritation, and persistent redness.¹

One frustrating aspect of E. faecalis-related vaginitis is that it is frequently unrecognized or dismissed. Standard screening for vaginal infections often focuses on bacterial vaginosis and yeast, and aerobic vaginitis doesn’t show up on the same tests. A clinician who isn’t specifically looking for it may miss it entirely, leaving patients cycling through treatments that don’t address the actual problem.¹

How Aerobic Vaginitis Differs from Bacterial Vaginosis

Both aerobic vaginitis and bacterial vaginosis involve a loss of lactobacilli, but they diverge sharply after that point. In bacterial vaginosis, the lactobacilli are replaced primarily by anaerobic organisms that form a biofilm. The hallmark is a thin, grayish-white discharge with a fishy odor, and the vaginal walls typically don’t look inflamed. In aerobic vaginitis, the replacement organisms are aerobic bacteria like E. faecalis, Group B Streptococcus, or Staphylococcus aureus, and the defining feature is active inflammation with redness, epithelial disruption, and immune cells flooding the discharge.¹

This distinction has practical consequences. Bacterial vaginosis is treated with metronidazole or clindamycin, which target anaerobic bacteria. Those drugs do nothing for E. faecalis, which is an aerobic organism with intrinsic resistance to several antibiotic classes. Treating aerobic vaginitis as if it were BV is a common clinical mistake, and it partly explains why some patients don’t improve after standard BV therapy. Research supports treating these as separate conditions, though it also acknowledges that vaginal ecosystem disruptions don’t always fall neatly into one category or the other.⁶

Colonization Without Symptoms

Not everyone who carries E. faecalis in the vagina develops symptoms. Studies of pregnant women have found vaginal colonization rates around 8%, with E. faecalis accounting for roughly 90% of all enterococcal isolates detected.⁷ Many of these women had no vaginal complaints at all. The bacterium was simply present at low levels, held in check by whatever lactobacilli remained.

This raises a question that comes up frequently: if E. faecalis is found on a vaginal culture but you feel fine, does it need treatment? In most cases, asymptomatic colonization in a non-pregnant person is left alone. The thinking is that low-level carriage is common and that treating it with antibiotics risks doing more harm than good by further disrupting the vaginal flora. The calculus changes during pregnancy, as discussed below, because even low-level colonization carries specific obstetric risks.

Risks During Pregnancy

E. faecalis colonization of the vaginal tract during pregnancy is a concern that goes beyond the mother’s own symptoms. The bacterium has been linked to serious pregnancy complications including spontaneous abortion, premature birth, puerperal sepsis, and abscesses.⁸ It is considered one of the major gram-positive bacteria, alongside Group B Streptococcus and Staphylococcus aureus, implicated in preterm labor and neonatal infections such as meningitis and sepsis.⁹

One cohort study examining neonatal outcomes found that E. faecalis in the maternal genital tract showed a significant relationship with intrauterine inflammation. Newborns whose mothers carried E. faecalis had a substantially higher risk of necrotizing enterocolitis, a dangerous intestinal condition in premature infants.¹⁰ The mechanism appears to involve the bacterium ascending into the uterine cavity and triggering inflammation of the fetal membranes (chorioamnionitis), which can precipitate preterm delivery and expose the newborn to infection during or before birth.

Because of these risks, vaginal cultures that identify E. faecalis during pregnancy typically prompt treatment even if the mother is asymptomatic. This is a different approach than for non-pregnant carriers, and it reflects the vulnerability of the pregnancy itself and the newborn to this particular organism.

E. Faecalis and the Uterus

E. faecalis doesn’t always stay confined to the vaginal canal. It can ascend into the uterus, and when it does, it has been linked to chronic endometritis, a low-grade persistent inflammation of the uterine lining. This condition is a recognized cause of implantation failure and recurrent pregnancy loss in people undergoing fertility treatment. E. faecalis is one of the opportunistic pathogens frequently found in the endometrium of patients diagnosed with chronic endometritis, and research suggests it damages endometrial receptivity through the production of extracellular superoxide, a reactive oxygen molecule that causes inflammatory injury to the tissue.¹¹

This superoxide production is worth paying attention to because it distinguishes E. faecalis from many other vaginal pathogens. Comparisons of strains isolated from bloodstream infections versus those living quietly in the gut have found that the more pathogenic strains produce superoxide far more often, suggesting that this trait contributes meaningfully to the bacterium’s ability to cause tissue damage.¹ For anyone experiencing unexplained infertility or recurrent miscarriage, having the endometrium evaluated for chronic endometritis, potentially caused by ascending E. faecalis, is a step that’s increasingly on the radar of reproductive medicine specialists.

The Cervical Cancer Connection

One area of emerging research concerns the relationship between E. faecalis-driven aerobic vaginitis and cervical abnormalities. When E. faecalis colonization pushes the vaginal pH above 5, the resulting environment appears to interact unfavorably with high-risk HPV infections. In HPV-positive women, an elevated vaginal pH associated with E. faecalis has been identified as a potential association for cervical intraepithelial neoplasia, the precancerous changes in cervical cells that can eventually progress to cervical cancer.¹ A dedicated literature review on this topic identified E. faecalis as a potential additional risk factor in the progression from cervical intraepithelial neoplasia to cervical cancer.⁸

This doesn’t mean that E. faecalis causes cancer. HPV is the primary driver of cervical cancer, and that hasn’t changed. What the research suggests is that the chronic inflammatory state and altered pH created by E. faecalis colonization might create a more permissive environment for HPV-related cervical changes. It’s an association at this stage, not a proven causal chain, and much more work is needed to clarify the mechanism. But it does add another reason to take persistent aerobic vaginitis seriously rather than dismissing it as a minor nuisance, especially in women who are also HPV-positive.

Why E. Faecalis Is Difficult to Treat

E. faecalis is intrinsically resistant to several classes of antibiotics, including cephalosporins and aminoglycosides at standard doses. This natural resistance is part of what makes it such a successful opportunist. When a course of broad-spectrum antibiotics wipes out lactobacilli and other susceptible vaginal flora, E. faecalis survives and fills the newly vacant ecological space. The very intervention meant to treat one infection can set the stage for E. faecalis to take hold.³

Adding to the challenge, E. faecalis forms biofilms on mucosal surfaces. Biofilms are structured communities of bacteria encased in a self-produced matrix that shields them from both the immune system and antibiotics. This is one reason why E. faecalis infections tend to recur: even after a course of targeted antibiotics clears the free-floating bacteria, organisms embedded in the biofilm can survive and re-seed the infection once treatment ends. Research into whether vaginal estrogen can help prevent biofilm formation and recurrence has so far not shown a clear benefit.⁵

Treatment typically involves antibiotics chosen based on susceptibility testing, since resistance patterns vary between strains and regions. Ampicillin remains effective against many E. faecalis strains, but vancomycin-resistant enterococci (VRE) are an increasing concern in hospital settings. For vaginal infections specifically, treatment often needs to be combined with strategies to restore lactobacilli afterward, since killing E. faecalis without repopulating the protective flora just sets the cycle up to repeat. Some clinicians recommend vaginal probiotics containing L. crispatus or L. rhamnosus following antibiotic treatment, though the evidence for their effectiveness in this specific context is still limited.

The Link Between Vaginal and Urinary E. Faecalis Infections

If you’ve been diagnosed with recurrent E. faecalis urinary tract infections, there’s a reasonable chance the vagina is serving as a reservoir. The same proximity that allows gut bacteria to migrate to the vagina also allows vaginal bacteria to ascend into the urethra and bladder. E. faecalis colonizing the vaginal introitus (the opening) can repeatedly seed the urinary tract, creating a frustrating cycle of UTIs that keep coming back despite appropriate antibiotic treatment for each individual episode.

This reservoir effect is something that UTI treatment alone doesn’t address. Clearing the bladder infection without dealing with vaginal colonization leaves the source intact. For people caught in this pattern, a vaginal culture can be informative. If E. faecalis is found in both sites, addressing the vaginal colonization alongside the urinary infection and working to restore vaginal lactobacilli may help break the recurrence cycle. The challenge, as with all E. faecalis treatment, is the bacterium’s biofilm-forming capacity and antibiotic resistance, which can make full eradication difficult.

Prevalence in Late Pregnancy

Screening studies give a sense of how common vaginal E. faecalis carriage actually is. In one study of over 600 pregnant women screened in late pregnancy, about 8% carried enterococci in the vagina, and nearly 90% of those isolates were E. faecalis specifically, with E. faecium and rarer species making up the remainder.⁷ Those numbers suggest that a meaningful minority of pregnant women carry the organism at any given time, most without knowing it. Whether universal screening for E. faecalis in pregnancy would improve outcomes (the way Group B Strep screening does) is a question that hasn’t been settled. Current obstetric guidelines don’t mandate it, but the evidence linking E. faecalis to intrauterine inflammation and neonatal complications suggests the conversation isn’t over.

1
PubMed Central. Aerobic Vaginitis Caused by Enterococcus Faecalis – Clinical Features and Treatment
2
PubMed Central. Enterococcal-host interactions in the gastrointestinal tract and beyond
3
PubMed Central. Genome-Wide Mutagenesis Identifies Factors Involved in Enterococcus faecalis Vaginal Adherence and Persistence
4
PubMed Central. Vaginal microbiota and the potential of Lactobacillus derivatives in maintaining vaginal health
5
PubMed. Evolving Enterococcus faecalis Biofilms and Urinary Tract Infection Relapse: Does Vaginal Estrogen Matter?
6
Oxford University Press. Bacterial Vaginosis vs. Aerobic Vaginitis: An Unresolved Conundrum?
7
Archives of Clinical Infectious Diseases. Vaginal Colonization and Susceptibility to Antibiotics of Enterococci During Late Pregnancy in Kerman City, Iran
8
Clinical and Experimental Obstetrics & Gynecology. Aerobic Vaginitis: is Enterococcus faecalis Another Risk Factor in the Progression of Cervical Intraepithelial Neoplasia to Cervical Cancer—Literature Review
9
PubMed Central. Perinatal Gram-Positive Bacteria Exposure Elicits Distinct Cytokine Responses In Vitro
10
PubMed. Neonatal outcome of preterm infants born to mothers with abnormal genital tract colonisation and chorioamnionitis: a cohort study
11
PubMed. Extracellular superoxide produced by Enterococcus faecalis reduces endometrial receptivity via inflammatory injury